Carcinoma, Mucoepidermoid clinical trials
The registry lists 4 studies for Carcinoma, Mucoepidermoid across 2 countries. 0 are recruiting or about to start. 1 of them are mainly about Carcinoma, Mucoepidermoid (how this is decided). Per ClinicalTrials.gov, last updated 2025-02-17.
Who runs them
Poseida Therapeutics, Inc. (1) · Klus Pharma Inc. (1) · Massachusetts General Hospital (1) · Ain Shams University (1)
Who these studies take
No Carcinoma, Mucoepidermoid study is recruiting now.
Across all 4 studies, recruiting or not: 0% stop at 75 or younger and 0% at 65; 0% take children; 0% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. search them.
- P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)TerminatedNCT04249947Phase 11 country
- Intensity-Modulated or Proton Radiation Therapy for Sinonasal MalignancyActive, not recruitingNCT01586767Not applicable1 country
- Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneCompletedNCT03602079Phase 1/21 country
- Surgical Management of Multiple Mucoepidermoid Carcinoma and AdenocarcinomaCompletedNCT03988959Not applicable1 country